AndreaBozzo/ceres-open-data-index huggingface dataset:
Monthly Cumulative Number and Percent of Persons Who Receive ≥1 Influenza Vaccination Doses and Comparison Between 2023-2024 and Two Previous Seasons, by Jurisdiction, United States

Monthly Cumulative Number and Percent of Persons Who Receive ≥1 Influenza Vaccination Doses and Comparison Between 2023-2024 and Two Previous Seasons, by Jurisdiction, United States

• Influenza vaccination coverage for children and adults is assessed through U.S. jurisdictions’ Immunization Information Systems (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group. More information about the IIS can be found at https://www.cdc.gov/vaccines/programs/iis/about.html. 

• Influenza vaccination coverage estimate numerators include the number of people receiving at least one dose of influenza vaccine in a given flu season, based on information that state, territorial, and local public health agencies report to CDC. Some jurisdictions’ data may include data submitted by tribes. Estimates include persons who are deceased but received a vaccination during the current season. People receiving doses are attributed to the jurisdiction in which the person resides unless noted otherwise. Quality and completeness of data may vary across jurisdictions. Influenza vaccination coverage denominators are obtained from 2020 U.S. Census Bureau population estimates. 

• Monthly estimates shown are cumulative, reflecting all persons vaccinated from July through a given month of that flu season. Cumulative estimates include any historical data reported since the previous submission. National estimates are not presented since not all U.S. jurisdictions are currently reporting their IIS data to CDC. Jurisdictions reporting data to CDC include U.S. states, some localities, and territories. 

• Because IIS data contain all vaccinations administered within a jurisdiction rather than a sample, standard errors were not calculated and statistical testing for differences in estimates across years were not performed. 

• Laws and policies regarding the submission of vaccination data to an IIS vary by state, which may impact the completeness of vaccination coverage reflected for a jurisdiction. More information on laws and policies are found at https://www.cdc.gov/vaccines/programs/iis/policy-legislation.html. 

• Coverage estimates based on IIS data are expected to differ from National Immunization Survey (NIS) estimates for children (https://www.cdc.gov/flu/fluvaxview/dashboard/vaccination-coverage-race.html)                 
and adults (https://www.cdc.gov/flu/fluvaxview/dashboard/vaccination-adult-coverage.html) because NIS estimates are based on a sample that may not be representative after survey weighting and vaccination status is determined by survey respondent rather than vaccine records or administrations, and quality and completeness of IIS data may vary across jurisdictions. In general, NIS estimates tend to overestimate coverage due to overreporting and IIS estimates may underestimate coverage due to incompleteness of data in certain jurisdictions.
Michigan (MI)

This report uses 2008 to 2010 National Survey on Drug Use and Health (NSDUH) to assess past year alcohol use disorder and illicit drug use disorder among persons aged 12 or older for Michigan overall and for substate regions within Michigan. Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE).
Compound 527428: Limonen-4-ol

Chemical compound data from PubChem database. IUPAC Name: 4-methyl-1-prop-1-en-2-ylcyclohex-3-en-1-ol. Molecular Formula: C10H16O. Molecular Weight: 152.23. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530761: m-Methoxybenzoic acid, 3,5-difluorophenyl ester

Chemical compound data from PubChem database. IUPAC Name: (3,5-difluorophenyl) 3-methoxybenzoate. Molecular Formula: C14H10F2O3. Molecular Weight: 264.22. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Dutasteride and tamsulosin hydrochloride

Dutasteride and Tamsulosin Hydrochloride is a prescription capsule combining two medications to treat symptoms of an enlarged prostate (benign prostatic hyperplasia). Dutasteride reduces prostate size by inhibiting hormone production, while tamsulosin relaxes prostate muscles for easier urination. Taken orally, it's available as 0.5 mg dutasteride and 0.4 mg tamsulosin per capsule. This information was generated using AI and is provided for informational and research purposes only.
Compound 530781: p-Methoxybenzoic acid, 5-fluoro-2-nitrophenyl ester

Chemical compound data from PubChem database. IUPAC Name: (5-fluoro-2-nitrophenyl) 4-methoxybenzoate. Molecular Formula: C14H10FNO5. Molecular Weight: 291.23. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528765: Tricyclo[5.2.1.0(2.6)]deca-3,8-diene, 1,3-dimethyl

Chemical compound data from PubChem database. IUPAC Name: 1,3-dimethyltricyclo[5.2.1.02,6]deca-3,8-diene. Molecular Formula: C12H16. Molecular Weight: 160.25. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530775: p-Toluic acid, 2-bromo-4-fluorophenyl ester

Chemical compound data from PubChem database. IUPAC Name: (2-bromo-4-fluorophenyl) 4-methylbenzoate. Molecular Formula: C14H10BrFO2. Molecular Weight: 309.13. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528856: 1-(Methylthio)propyl propyl disulfide

Chemical compound data from PubChem database. IUPAC Name: 1-methylsulfanyl-1-(propyldisulfanyl)propane. Molecular Formula: C7H16S3. Molecular Weight: 196.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E399813-T1: [Translated] METHOD FOR USING POLYCARBONATES

A process for making a high molecular weight (co)polycarbonate resin is disclosed. The process entails (i) obtaining at least one member selected from the group low molecular weight residue (weight average molecular weight 15,000 to 30,000) of aromatic (co)polycarbonate production, waste of (co)polycarbonate production, remainders of (co)polycarbonate production and (co)polycarbonate recyclate (ii) melting the said member in a suitable vessel to obtain a melt and (iii) feeding the melt into a reactor optionally along with at least one bisphenol or oligocarbonate having terminal OH groups and further optionally with a transesterification catalyst, and (iv) subjecting the melt to transesterification reaction at a temperature of 250 to 350° C., at a pressure below 5 mbar and residence time of 0.02-4 hours.
Exploring Address Validation Processes and Tools

This webinar will explore address validation processes and tools. Learn how Texas and California approached the challenges of address validation in their respective child welfare case management systems. Speakers will discuss how millions of addresses were standardized, what decisions were made, what problems were encountered and how they were solved, interface considerations, cost issues, tools used, lessons learned, and future system considerations.

The following speakers will be presenting at this webinar:

Metadata-only record linking to the original dataset. Open original dataset below.
NSDUH 2018 Questionnaire Dwelling Unit-Level and Person Pair-Level Sampling Weight Calibration

NSDUH allows for estimating characteristics at the person level, pair level, and household or QDU level. This report describes the weight calibration methods used for the pair- and QDU-level respondents. As described in the person-level report, NSDUH is an annual survey of about 67,500 people selected from the civilian, noninstitutionalized population aged 12 or older from all 50 states and the District of Columbia. A coordinated sample design was developed for the 2014 through 2018 NSDUHs. The coordinated design facilitated 50 percent overlap in third-stage units (area segments) within each successive 2-year period from 2014 through 2018.
PKA, PKC, and AKAP localization in and around the neuromuscular junction

Background
          One mechanism that directs the action of the second messengers, cAMP and diacylglycerol, is the compartmentalization of protein kinase A (PKA) and protein kinase C (PKC). A-kinase anchoring proteins (AKAPs) can recruit both enzymes to specific subcellular locations via interactions with the various isoforms of each family of kinases. We found previously that a new class of AKAPs, dual-specific AKAPs, denoted D-AKAP1 and D-AKAP2, bind to RIα in addition to the RII subunits.
        
        
          Results
          Immunohistochemistry and confocal microscopy were used here to determine that D-AKAP1 colocalizes with RIα at the postsynaptic membrane of the vertebrate neuromuscular junction (NMJ) and the adjacent muscle, but not in the presynaptic region. The labeling pattern for RIα and D-AKAP1 overlapped with mitochondrial staining in the muscle fibers, consistent with our previous work showing D-AKAP1 association with mitochondria in cultured cells. The immunoreactivity of D-AKAP2 was distinct from that of D-AKAP1. We also report here that even though the PKA type II subunits (RIIα and RIIβ) are localized at the NMJ, their patterns are distinctive and differ from the other R and D-AKAP patterns examined. PKCβ appeared to colocalize with the AKAP, gravin, at the postsynaptic membrane.
        
        
          Conclusions
          The kinases and AKAPs investigated have distinct patterns of colocalization, which suggest a complex arrangement of signaling micro-environments. Because the labeling patterns for RIα and D-AKAP 1 are similar in the muscle fibers and at the postsynaptic membrane, it may be that this AKAP anchors RIα in these regions. Likewise, gravin may be an anchor of PKCβ at the NMJ.
Compound 525988: 4-Methyl-2-nonylbenzo[b]thiophene

Chemical compound data from PubChem database. IUPAC Name: 4-methyl-2-nonyl-1-benzothiophene. Molecular Formula: C18H26S. Molecular Weight: 274.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E399616-T1: [Translated] METHOD AND DEVICE FOR MACHINE ASSEMBLY OF VALVE TRAIN PARTS

The valve key (25) has to be inserted exactly between the valve shaft (22) and the spring (23) supported valve spring retainer (24) during the assembly of the valve components to be used in the engine of a vehicle. In a first step the valve key (25) is positioned on top of the valve spring retainer (24) from where it can be easily taken by the mounting levers (38) belonging to the assembly unit and attached to the valve shaft (22).
Patent AT-E401196-T1: [Translated] METHOD AND DEVICE FOR PRODUCING AN OPHTHALMIC LENS

A method for marking an ophthalmic lens according to predetermined patterns includes supplying a plate (1) provided with engravings (4), filling the engravings (4) with marking ink, applying a pad (7) to the engravings (4), applying the pad (7) to the ophthalmic lens (5). The method involves a stage for pre-preparing the pad (7) in such a way that at least two movable with respect to each other inking portions (12, 13) are defined and a transformation stage for modifying the arrangement of the inking portions (12, 13) which is carried out between the stage for applying the pad (7) to the plate (1) and the stage for applying the inked pad to the lens (5).
2010 CMHS Uniform Reporting System (URS) Output Tables for Massachusetts

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2010. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
NSDUH 2022 Pair Level Sampling Weight Report

Learn about the techniques used to create weights for the 2022 National Survey on Drug Use and Health (NSDUH) at the pair and questionnaire dwelling unit (QDU) levels. NSDUH is designed so that some of the sampled households have both an adult and a youth respondent who are paired. Because of this, NSDUH allows for estimating characteristics at the person level, pair level, or QDU level. This report describes pair selection probabilities, the generalized exponential model (including predictor variables used), and the multiple weight components that are used for pair or QDU levels of analysis. An evaluation of the calibration weights is also included.Chapters:Introduces the report.Discusses the probability of selection for pairs and QDUs.Briefly describes of the generalized exponential model.Describes the predictor variables for the model calibration.Defines extreme weights.Discusses weight calibrations.Evaluates the calibration weights.Appendices include technical details about the model and the evaluations that were performed.
Patent AT-E400582-T1: [Translated] MYELIN BASIC PROTEIN PEPTIDE FRAGMENTS, THEIR PHARMACEUTICAL COMPOSITIONS AND USE AGAINST MULTIPLE SCLEROSIS

Human myelin basic protein (h-MBP) has a molecular weight of 18.5 KD and contains 170 amino acid residues. Synthetic peptides ranging in length from about 8 to 25 residues and covering the entire length of the protein have been produced. Antibodies to h-MBP (anti-MBP) were found to be neutralized by the synthetic peptides, in vitro, which span the h-MBP from about amino acid residue 61 to about amino acid residue 106. The peptides, which cover both the amino (about residues 1 to 63) and carboxy (about residues 117 to 162) terminals of h-MBP did not neutralize purified anti-MBP. Intrathecal administration of peptide MBP(75-95), MBP(86-95), or MBP(82-98) produced complete binding-neutralization of free (F) anti-MBP with no change in bound (B) levels. A control peptide MBP(35-58) had no effect on (F) or (B) anti-MBP levels. Intravenous administration of MBP(75-95), MBP(86-95), or MBP(82-98) resulted in significant decline of (F) and (B) CSF anti-MBP levels. Administration of MBP synthetic peptides to MS patients either intrathecally or intravenously did not have any adverse neurological effects and systemic complications did not occur. The MBP epitope for MS anti-MBP has been localized to an area between Pro86 and Pro95.
Patent AT-E400366-T1: [Translated] LIQUID DISPENSER WITH CHILD SAFE NOZZLE ARRANGEMENT

A dispenser body supports a nozzle cap (35) for rotation about a longitudinal axis thereof between ON and OFF positions. A nozzle cover (70) surrounds the nozzle cap (35), is freely rotatable about the nozzle cap and is movable along the longitudinal axis relative to the nozzle cap, to render the same child resistant. Engaging portions (62,74) on the nozzle cap (35) and the nozzle cover (70) are longitudinally spaced apart in a first longitudinal position to prevent rotation of the nozzle cap (35) by rotating the nozzle cover (70), thereby preventing the nozzle cap (35) from being rotated from one position to another. In a second longitudinal position of the nozzle cover (70) relative to the nozzle cap (35), the engaging portions (62,74) interengage to enable the nozzle cap (35) to be rotated by the nozzle cover (70) to enable the nozzle cap (35) to be rotated from one position to another. <IMAGE>
Compound 529188: 2-Aminopentane, mono-TMS

Chemical compound data from PubChem database. IUPAC Name: N-trimethylsilylpentan-2-amine. Molecular Formula: C8H21NSi. Molecular Weight: 159.34. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Archive for State AFCARS Report

The AFCARS Report (TAR) presents a national summary of foster care and adoption counts/data during a given fiscal year.

Alabama

Alaska

Arizona

Arkansas

California

Colorado

Connecticut

Delaware

District of Columbia

Florida

Georgia

Hawaii

Idaho

Illinois

Indiana

Iowa

Kansas

Kentucky

Louisiana

Maine

Maryland

Massachusetts

Michigan

Minnesota

Mississippi

Missouri

Montana

Nebraska

New Hampshire

New Jersey

New Mexico

New York

Nevada

North Carolina

North Dakota

Ohio

Oklahoma

Oregon

Pennsylvania

Puerto Rico

Rhode Island

South Carolina

South Dakota

Tennessee

Texas

Utah

Vermont

Virginia

Washington

West Virginia

Wisconsin

Wyoming

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 525422: 2-Methyl-5-thianonane

Chemical compound data from PubChem database. IUPAC Name: 1-butylsulfanyl-3-methylbutane. Molecular Formula: C9H20S. Molecular Weight: 160.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525713: p-Methylbenzylidene-(3-ethoxyphenyl)-amine

Chemical compound data from PubChem database. IUPAC Name: N-(3-ethoxyphenyl)-1-(4-methylphenyl)methanimine. Molecular Formula: C16H17NO. Molecular Weight: 239.31. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
U.S. State and Territorial Gathering Bans: March 11, 2020-May 31, 2021 by County by Day

State and territorial executive orders, administrative orders, resolutions, proclamations, and other official publicly available government communications are collected from government websites and cataloged and coded using Microsoft Excel by one or more coders with one or more additional coders conducting quality assurance.

Data were collected to determine when individuals in states and territories were subject to executive orders, administrative orders, resolutions, proclamations, and other official publicly available government communications related to  COVID-19 banning gatherings of various sizes either (1) generally, or specified that the gathering limit applied only when social distancing was not possible, or (2) even if participants practiced social distancing.

These data are derived from on the publicly available state and territorial executive orders, administrative orders, resolutions, and proclamations (“orders”) for COVID-19 that expressly ban gatherings found by the CDC, COVID-19 Community Intervention and Critical Populations Task Force, Monitoring and Evaluation Team & CDC, Center for State, Tribal, Local, and Territorial Support, Public Health Law Program from March 11, 2020 through May 31, 2021. These data will be updated as new orders are collected. Any orders not available through publicly accessible websites are not included in these data. Only official copies of the documents or, where official copies were unavailable, official press releases from government websites describing requirements were coded, as well as official government communications such as announcements that counties have progressed through new phases of reopening pursuant to an executive order, directive, or other executive branch action, and posted to government websites; news media reports on restrictions were excluded. Recommendations and guidance documents not included or adopted by reference in an order are not included in these data. These data do not include mandatory business closures, curfews, or requirements/recommendations for people to stay in their homes. Due to limitations of the National Environmental Public Health Tracking Network Data Explorer, these data do not include tribes or cities, nor was a distinction made between county orders that applied county-wide versus those that were limited to unincorporated areas of the county. Effective and expiration dates were coded using only the date provided; no distinction was made based on the specific time of the day the order became effective or expired. These data do not necessarily represent an official position of the Centers for Disease Control and Prevention.
Patent AT-E401269-T1: [Translated] CONVEYOR CHAIN

The chain conveyor has a number of chain elements (2) with a joint between each two successive chain elements with two transverse pivot axles (12,15), pivot bearing bolts and an intermediate element (3) on which the other chain element is supported. Pivot bearing bolt elements (14) protruding on both sides of the intermediate element towards the other pivot axis engage side elements (9,10) on the other end of the other chain element.
2013 CMHS Uniform Reporting System (URS) Tables for Indiana

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Tables for Indiana for 2013. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program.  State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Evaluation of thresholds for the detection of binding sites for regulatory proteins in

Background
          Sites in DNA that bind regulatory proteins can be detected computationally in various ways. Pattern discovery methods analyze collections of genes suspected to be co-regulated on the evidence, for example, of clustering of transcriptome data. Pattern searching methods use sequences with known binding sites to find other genes regulated by a given protein. Such computational methods are important strategies in the discovery and elaboration of regulatory networks and can provide the experimental biologist with a precise prediction of a binding site or identify a gene as a member of a set of co-regulated genes (a regulon). As more variations on such methods are published, however, thorough evaluation is necessary, as performance may differ depending on the conditions of use. Detailed evaluation also helps to improve and understand the behavior of the different methods and computational strategies.
        
        
          Results
          We used a collection of 86 regulons from Escherichia coli as datasets to evaluate two methods for pattern discovery and pattern searching: dyad analysis/dyad sweeping using the program Dyad-analysis, and multiple alignment using the programs Consensus/Patser. Clearly defined statistical parameters are used to evaluate the two methods in different situations. We placed particular emphasis on minimizing the rate of false positives.
        
        
          Conclusions
          As a general rule, sensors obtained from experimentally reported binding sites in DNA frequently locate true sites as the highest-scoring sequences within a given upstream region, especially using Consensus/Patser. Pattern discovery is still an unsolved problem, although in the cases where Dyad-analysis finds significant dyads (around 50%), these frequently correspond to true binding sites. With more robust methods, regulatory predictions could help identify the function of unknown genes.